Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.37−0.01 (-0.72%)
Close on Nov 17, 2026Market cap $103.10MP/E –Yield –
Health Catalyst total assets
Total assets on the balance sheet at the end of each period.
Health Catalyst's total assets was $358.60M at Jun 30, 2026. For fiscal 2025 it was $502.64M, down 41.5% from the year before. The highest annual figure on record is $858.93M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $502.64M | -41.5% |
| FY2024 | Dec 31, 2024 | $858.93M | +22.4% |
| FY2023 | Dec 31, 2023 | $701.81M | -6.7% |
| FY2022 | Dec 31, 2022 | $752.29M | -9.6% |
| FY2021 | Dec 31, 2021 | $832.10M | +44.0% |
| FY2020 | Dec 31, 2020 | $577.74M | +91.1% |
| FY2019 | Dec 31, 2019 | $302.36M | +172.5% |
| FY2018 | Dec 31, 2018 | $110.98M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $358.60M | -41.8% |
| Q1 FY2026 | Mar 31, 2026 | $412.20M | -53.8% |
| Q4 FY2025 | Dec 31, 2025 | $502.64M | -41.5% |
| Q3 FY2025 | Sep 30, 2025 | $587.13M | -27.8% |
| Q2 FY2025 | Jun 30, 2025 | $616.18M | -10.9% |
| Q1 FY2025 | Mar 31, 2025 | $891.54M | +28.3% |
| Q4 FY2024 | Dec 31, 2024 | $858.93M | +22.4% |
| Q3 FY2024 | Sep 30, 2024 | $813.05M | +14.0% |
| Q2 FY2024 | Jun 30, 2024 | $691.72M | -4.3% |
| Q1 FY2024 | Mar 31, 2024 | $695.11M | -7.6% |
| Q4 FY2023 | Dec 31, 2023 | $701.81M | -6.7% |
| Q3 FY2023 | Sep 30, 2023 | $712.92M | -8.2% |
| Q2 FY2023 | Jun 30, 2023 | $722.90M | -10.9% |
| Q1 FY2023 | Mar 31, 2023 | $752.30M | -8.8% |
| Q4 FY2022 | Dec 31, 2022 | $752.29M | -9.6% |
| Q3 FY2022 | Sep 30, 2022 | $776.20M | -8.2% |
| Q2 FY2022 | Jun 30, 2022 | $811.34M | +44.1% |
| Q1 FY2022 | Mar 31, 2022 | $824.92M | +44.4% |
| Q4 FY2021 | Dec 31, 2021 | $832.10M | +44.0% |
| Q3 FY2021 | Sep 30, 2021 | $845.51M | +48.2% |
| Q2 FY2021 | Jun 30, 2021 | $562.96M | +20.7% |
| Q1 FY2021 | Mar 31, 2021 | $571.22M | +85.0% |
| Q4 FY2020 | Dec 31, 2020 | $577.74M | +91.1% |
| Q3 FY2020 | Sep 30, 2020 | $570.66M | +78.3% |
| Q2 FY2020 | Jun 30, 2020 | $466.40M | +233.9% |
| Q1 FY2020 | Mar 31, 2020 | $308.76M | +178.2% |
| Q4 FY2019 | Dec 31, 2019 | $302.36M | – |
| Q3 FY2019 | Sep 30, 2019 | $319.97M | – |
| Q2 FY2019 | Jun 30, 2019 | $139.68M | – |
| Q4 FY2018 | Dec 31, 2018 | $110.98M | – |
See a number that looks wrong?